Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • scott_williams
    replied
    Additional info on mr J. O. Adams

    "Beijing Dragon Tech Biotechnology Limited (GenendraBiotech) to focus on second-generation sequencing (NGS), and for the field of science, protein molecular genomics, molecular biology, the genome, providing testing equipment, SBS Reagent Pack, entrapping packet sequence, molecular chemistry test package, PCR and real-time PCR instruments, gel electrophoresis systems, core technology competitive products. Companies academic leaders and CEOJMr. ADAMS scientists have several degrees and many years of relevant experience in molecular biology, biochemistry, genomics, etc., worked in related fields published several academic papers, and won the Nobel Prize, founded in the United States also successfully live their genomic tools company."

    Has he really won the nobel prize?
    Last edited by scott_williams; 03-07-2016, 08:38 AM.

    Leave a comment:


  • scott_williams
    replied
    Originally posted by dannyhi321 View Post
    In the light of the following information, yes I would say so, someone should inform Illumina, if they are not already aware.:-

    Domain Name: genedrabio.com
    Registry Registrant ID:
    Registrant Name: Tseegii Baasanjav
    Registrant Organization: Gendra Biotech, Inc.
    Registrant Street: 4730 Milano Way
    Registrant Street: CA
    Registrant City: Oceanside
    Registrant State/Province:
    Registrant Postal Code: 92087
    Registrant Country: US
    Registrant Phone: +1.8585252770
    Registrant Phone Ext:
    Registrant Fax:
    Registrant Fax Ext:
    Registrant Email: [email protected]


    <<<
    A company is registered on this same address by J. O. Adams



    Appears to be the same person associated with Azco, polonator and Max-Seq



    Leave a comment:


  • GenoMax
    replied
    If genedrabio has actually managed to reverse-engineer SBS chemistry (even for GAII) then that may be a feat in itself.

    There is more information about SBS here: http://www.genedrabio.com/en/seq_reagents.php

    Are Illumina's original patents on this expiring?
    Last edited by GenoMax; 03-02-2016, 12:21 PM.

    Leave a comment:


  • gringer
    replied
    Originally posted by dannyhi321 View Post
    Do you have a ref for that? I would find it useful and interesting, as I am sure, many others will.
    https://www.google.com/patents/US5795782 (1995)

    Leave a comment:


  • NextGenSeq
    replied
    Originally posted by dannyhi321 View Post
    Do you have a ref for that? I would find it useful and interesting, as I am sure, many others will.

    Leave a comment:


  • NextGenSeq
    replied
    Originally posted by gringer View Post
    The initial patent around the MinION technology is about 20 years old....
    But this company is using SBS chemistry which is basically a modification of Sanger sequencing which is about 40 years old.

    Leave a comment:


  • dannyhi321
    replied
    Originally posted by gringer View Post
    The initial patent around the MinION technology is about 20 years old....
    Do you have a ref for that? I would find it useful and interesting, as I am sure, many others will.

    Leave a comment:


  • gringer
    replied
    Originally posted by NextGenSeq View Post
    Copying 10 year old technology doesn't seem very new to me.
    The initial patent around the MinION technology is about 20 years old....

    Leave a comment:


  • dannyhi321
    replied
    Originally posted by HESmith View Post
    From the 'Investors' page:

    "We will start by fulfilling the research needs in Asia…"

    Is it really racist to note that some products are available only in certain markets?
    In the light of the following information, yes I would say so, someone should inform Illumina, if they are not already aware.:-

    Domain Name: genedrabio.com
    Registry Domain ID: 1942725406_DOMAIN_COM-VRSN
    Registrar WHOIS Server: whois.ascio.com
    Registrar URL: http://www.ascio.com
    Updated Date: 2015-06-28T02:29:22Z
    Creation Date: 2015-06-28T00:00:00Z
    Registrar Registration Expiration Date: 2016-06-28T02:28:51Z
    Registrar: Ascio Technologies, Inc
    Registrar IANA ID: 106
    Registrar Abuse Contact Email: [email protected]
    Registrar Abuse Contact Phone: +44.2070159370
    Domain Status: OK
    Registry Registrant ID:
    Registrant Name: Tseegii Baasanjav
    Registrant Organization: Gendra Biotech, Inc.
    Registrant Street: 4730 Milano Way
    Registrant Street: CA
    Registrant City: Oceanside
    Registrant State/Province:
    Registrant Postal Code: 92087
    Registrant Country: US
    Registrant Phone: +1.8585252770
    Registrant Phone Ext:
    Registrant Fax:
    Registrant Fax Ext:
    Registrant Email: [email protected]
    Registry Admin ID:
    Admin Name: Host Master
    Admin Organization: One.com
    Admin Street: Kalvebod Brygge 24
    Admin City: Copenhagen V
    Admin State/Province: Copenhagen V
    Admin Postal Code: 1560
    Admin Country: DK
    Admin Phone: +45.46907100
    Admin Phone Ext:
    Admin Fax: +45.70205872
    Admin Fax Ext:
    Admin Email: [email protected]
    Registry Tech ID:
    Tech Name: Host Master
    Tech Organization: One.com
    Tech Street: Kalvebod Brygge 24
    Tech City: Copenhagen V
    Tech State/Province: Copenhagen V
    Tech Postal Code: 1560
    Tech Country: DK
    Tech Phone: +45.46907100
    Tech Phone Ext:
    Tech Fax: +45.70205872
    Tech Fax Ext:
    Tech Email: [email protected]
    Name Server: ns01.one.com
    Name Server: ns02.one.com
    DNSSEC: unsigned
    URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
    >>> Last update of WHOIS database: 2016-03-02T16:55:16 UTC <<<
    Last edited by dannyhi321; 03-02-2016, 09:21 AM. Reason: clarification

    Leave a comment:


  • scott_williams
    replied
    Originally posted by HESmith View Post
    From the 'Investors' page:

    "We will start by fulfilling the research needs in Asia…"

    Is it really racist to note that some products are available only in certain markets?
    Maybe they have IP issues outside of Asia?

    Leave a comment:


  • HESmith
    replied
    From the 'Investors' page:

    "We will start by fulfilling the research needs in Asia…"

    Is it really racist to note that some products are available only in certain markets?
    Last edited by HESmith; 02-29-2016, 12:39 PM.

    Leave a comment:


  • dannyhi321
    replied
    Originally posted by GenoMax View Post
    Your guess is as good as ours :-)

    I wonder if this is an "illumina" clone meant only for the asian markets (like some phones out there). Illustration looks suspiciously like a GAIIx.
    Suspicious ..yes..

    Plagiarism, hypocrisy AND racism…classy!

    Leave a comment:


  • NextGenSeq
    replied
    Copying 10 year old technology doesn't seem very new to me.

    Leave a comment:


  • GenoMax
    replied
    Your guess is as good as ours :-)

    I wonder if this is an "illumina" clone meant only for the asian markets (like some phones out there). Illustration looks suspiciously like a GAIIx.

    Leave a comment:


  • scott_williams
    started a topic New player?

    New player?

    Is this a new player?

Latest Articles

Collapse

  • seqadmin
    Advanced Methods for the Detection of Infectious Disease
    by seqadmin




    The recent pandemic caused worldwide health, economic, and social disruptions with its reverberations still felt today. A key takeaway from this event is the need for accurate and accessible tools for detecting and tracking infectious diseases. Timely identification is essential for early intervention, managing outbreaks, and preventing their spread. This article reviews several valuable tools employed in the detection and surveillance of infectious diseases.
    ...
    11-27-2023, 01:15 PM
  • seqadmin
    Strategies for Investigating the Microbiome
    by seqadmin




    Microbiome research has led to the discovery of important connections to human and environmental health. Sequencing has become a core investigational tool in microbiome research, a subject that we covered during a recent webinar. Our expert speakers shared a number of advancements including improved experimental workflows, research involving transmission dynamics, and invaluable analysis resources. This article recaps their informative presentations, offering insights...
    11-09-2023, 07:02 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Yesterday, 02:24 PM
0 responses
12 views
0 likes
Last Post seqadmin  
Started by seqadmin, Yesterday, 07:37 AM
0 responses
23 views
0 likes
Last Post seqadmin  
Started by seqadmin, 12-04-2023, 08:23 AM
0 responses
9 views
0 likes
Last Post seqadmin  
Started by seqadmin, 12-01-2023, 09:55 AM
0 responses
24 views
0 likes
Last Post seqadmin  
Working...
X